Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Maitri Enterprises's ROE % for the quarter that ended in Mar. 2026 was 35.89%. Maitri Enterprises's PB Ratio for the quarter that ended in Mar. 2026 was 2.21.
Maitri Enterprises's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was 16.24%.
Maitri Enterprises ROE % Adjusted to Book Value Related Terms
Maitri Enterprises ROE % Adjusted to Book Value Historical Data
* Premium members only.
The historical data trend for Maitri Enterprises's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Maitri Enterprises ROE % Adjusted to Book Value Chart
Maitri Enterprises ROE % Adjusted to Book Value Competitor Comparison
For the Pharmaceutical Retailers subindustry, Maitri Enterprises's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Maitri Enterprises ROE % Adjusted to Book Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Maitri Enterprises's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Maitri Enterprises's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of 16.24% mean?
Maitri Enterprises (BOM:513430) has a ROE % Adjusted to Book Value of 16.24% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Maitri Enterprises and its competitors.
Is Maitri Enterprises' ROE % Adjusted to Book Value too high?
Maitri Enterprises' current ROE % Adjusted to Book Value is 16.24%. Overall, Maitri Enterprises has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Maitri Enterprises' ROE % Adjusted to Book Value compare to competitors?
Maitri Enterprises' ROE % Adjusted to Book Value of 16.24% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Healthcare Providers & Services company?
A good ROE % Adjusted to Book Value depends on the Healthcare Providers & Services industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Maitri Enterprises and its competitors. Maitri Enterprises's current ROE % Adjusted to Book Value is 16.24%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maitri Enterprises stock overvalued right now?
Based on GuruFocus' analysis, Maitri Enterprises (BOM:513430) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹52.38, compared to a current price of ₹41.45 — trading 20.9% below its estimated fair value. The current ROE % Adjusted to Book Value is 16.24%. Maitri Enterprises' overall GF Score™ is 75/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Maitri Enterprises (BOM:513430), the current ROE % Adjusted to Book Value is 16.24% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Maitri Enterprises (BOM:513430) Overvalued in 2026?
Based on GuruFocus' analysis, Maitri Enterprises stock appears to be undervalued.
The current stock price of ₹41.45 is trading 20.9% below its estimated GF Value™ of ₹52.38.
GuruFocus considers Maitri Enterprises to be Modestly Undervalued.
Key valuation signals for BOM:513430:
ROE % Adjusted to Book Value: 16.24%
GF Value™: ₹52.38 vs. price of ₹41.45 (20.9% below fair value)
No single metric tells the full story. See the BOM:513430 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Maitri Enterprises Ltd is engaged in the trading of pharmaceutical and medical goods in India. It is also involved in the sale of services by way of a works contract. The company's operating and reporting segments are: Pharmaceutical Goods, and Infrastructure and Real Estate. The majority of its revenue is generated from the provision of work contract services.
75GF Score
Get the complete analysis for BOM:513430
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:513430 has been successfully added to your 
